Today’s Prayer | The Church of England
Join us in today’s prayer.
Related Articles
FAST exam with clot in pelvis #pocus #emergencymedicine #fast
Nice example showing how clotted blood can appear gray on #POCUS
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer
Nature Cancer – Ganguli et al. show that CDKN2A loss in Barrett’s esophagus prevents esophageal adenocarcinoma initiation by counterselecting subsequent TP53 loss and report context-dependent…
The U.S. Surgeon General wants cancer warnings on alcohol. Here’s why
Drinking alcohol raises the risk of developing seven types of cancer, according to a new advisory from U.S. Surgeon General Vivek Murthy.
ExIOnc Survey Latin America
This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value entered…
FDA Signals Potential for Standard Approval of Paxalisib in Glioblastoma
The FDA indicated paxalisib’s overall survival data could support standard approval in glioblastoma, as supported by GBM-AGILE study findings.
Comprehensive genomic characterization of early-stage bladder cancer
Nature Genetics – A genomic and transcriptomic analysis of nonmuscle-invasive bladder cancer identifies four molecular subtypes, and associates whole-genome duplication and immune exhaustion with…
Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations
Nature Medicine – Machine-learning-based and population-level electronic health record data–based emulation of landmark phase 3 randomized controlled trials (RCTs) in oncology across a range…
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703
The BMT CTN 1703 phase III trial confirmed that graft-versus-host disease (GVHD) prophylaxis with post-transplantation cyclophosphamide (PTCy), tacrolimus (Tac), and mycophenolate mofetil (MMF) results in…
Her Mental Health Treatment Was Helping. That’s Why Insurance Cut Off Her Coverage.
Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental health treatment.
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY)
AbstractPurpose:. Angiogenesis inhibitors are known to modify tumor immunity. Combination of angiogenesis inhibitors with immune checkpoint inhibitors has shown efficacy against many types of cancers,…
